Who should not take HGH therapy?
HGH therapy should not be used in patients with active cancer or tumors. HGH therapy should be discontinued if evidence of cancer develops. HGH should not be initiated to treat patients with acute critical illness due to complications following open-heart or abdominal surgery, multiple accidental trauma, or to patients having acute respiratory failure. HGH therapy should not be used for growth promotion in patients with closed epiphyses – that is, whose long bones have stopped growing. HGH is contraindicated in patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment. Unless patients with Prader-Willi syndrome also have a diagnosis of growth hormone deficiency, Growth Hormone therapy is not indicated for the long-term treatment of pediatric patients who have growth failure due to genetically confirmed Prader-Willi syndrome.
HGH therapy should not be used in patients with active cancer or tumors. HGH therapy should be discontinued if evidence of cancer develops. HGH should not be initiated to treat patients with acute critical illness due to complications following open-heart or abdominal surgery, multiple accidental trauma, or to patients having acute respiratory failure. HGH therapy should not be used for growth promotion in patients with closed epiphyses – that is, whose long bones have stopped growing. HGH is contraindicated in patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment. Unless patients with Prader-Willi syndrome also have a diagnosis of growth hormone deficiency, Growth Hormone therapy is not indicated for the long-term treatment of pediatric patients who have growth failure due to genetically confirmed Prader-Willi syndrome. Back to Top Q: What if I am interested in injectable Growth Hormone? A: Growth Hormone requires a physician consultation.
